BiotechTube

Ranolazine + Placebo to match ranolazine

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Myocardial Perfusion Imaging

Conditions

Myocardial Perfusion Imaging, Myocardial Ischemia

Trial Timeline

Sep 1, 2010 → Sep 1, 2012

NCT ID
NCT01221272

About Ranolazine + Placebo to match ranolazine

Ranolazine + Placebo to match ranolazine is a approved stage product being developed by Gilead Sciences for Myocardial Perfusion Imaging. The current trial status is completed. This product is registered under clinical trial identifier NCT01221272. Target conditions include Myocardial Perfusion Imaging, Myocardial Ischemia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01221272ApprovedCompleted

Competing Products

20 competing products in Myocardial Perfusion Imaging

See all competitors
ProductCompanyStageHype Score
Butylphthalide + Butylphthalide placeboCSPC Pharmaceutical Group LimitedPhase 3
76
AbciximabEli LillyApproved
85
Prasugrel + ClopidogrelDaiichi SankyoPhase 3
77
Regadenoson + gadofoveset trisodiumAstellas PharmaPhase 2
52
Half-dose of the Tc99-m sestamibi (Cardiolite)Astellas PharmaPre-clinical
23
No interventionAstellas PharmaPre-clinical
23
Empagliflozin + PlaceboEli LillyPhase 3
77
Abciximab + Abciximab placeboEli LillyPhase 3
77
Intracoronary infusion of enriched bone marrow-derived progenitor cells + Placebo medium supplemented with autologous serumEli LillyPhase 3
77
AbciximabEli LillyApproved
85
abciximab placebo; reteplase placebo, abciximab, abciximab + Abciximab; reteplase; abciximab placebo; abciximab + abciximab; reteplase placebo; abciximab placebo; abciximab + abciximab placebo; reteplase placebo, abciximab, abciximab + abciximab; reteplase placebo; abciximab placebo; abciximab + Abciximab; reteplase; abciximab placebo; abciximabEli LillyPhase 3
77
fibrinolytic therapy or combination reduced fibrinolytic therapyEli LillyPhase 3
77
abciximabEli LillyApproved
85
tenecteplase + enoxaparin + clopidogrelEli LillyPhase 2/3
65
Thrombolytic therapyEli LillyPre-clinical
23
TicagrelorAstraZenecaPre-clinical
23
TicagrelorAstraZenecaPhase 2
52
Dual-antiplatelet therapy + Dual-antiplatelet therapyAstraZenecaPre-clinical
23
Metoprolol- Toprol XL + Metoprolol- LopressorAstraZenecaPhase 1
33
Ticagrelor orodispersible tablets + Ticagrelor standard tabletsAstraZenecaPhase 3
77

Other Products from Gilead Sciences

Ranolazine + PlaceboApproved
84
Truvada + Atazanavir + RitonavirApproved
84
Truvada + efavirenzApproved
84
B/F/TAF + Atripla + B/F/TAF Placebo + Atripla PlaceboApproved
84
TDF + Placebo Vaginal Gel + Vaginal TFV Gel + Placebo TabletsApproved
84